As medical professionals, it's important to stay informed about uncommon conditions that may affect our patients. Legg-Calve-Perthes Disease is one such condition that primarily affects children between the ages of 4 and 10 years old. It occurs when blood supply to the femoral head (top part of the thigh bone) is disrupted, causing a degeneration of bone tissue and eventual collapse. In this blog post, we'll explore the causes and symptoms of Legg-Calve-Perthes Disease so that you can better diagnose and treat your patients with this challenging condition.
The exact cause of Legg-Calve-Perthes Disease remains unknown. However, it is believed that a disruption in blood flow to the femoral head may be the primary trigger for the condition. Some experts believe that a genetic predisposition may also play a role.
Other risk factors include age; children between 4 and 10 years old are most commonly affected by this disease. Boys are more likely than girls to develop Legg-Calve-Perthes Disease, with the ratio being approximately four boys affected for every one girl.
Certain medical conditions such as sickle cell disease or clotting disorders can increase the risk of developing this condition. It's worth noting that some medications like steroids have been known to contribute towards Legg-Calve-Perthes Disease development.
While there is no definitive answer on what causes Legg-Calve-Perthes Disease, understanding potential risk factors can help you diagnose and treat patients who present with this challenging condition more effectively.
Legg-Calve-Perthes disease, also known as Perthes disease or avascular necrosis of the femoral head, is a condition that affects children between 4 to 10 years old. The disorder causes inadequate blood flow to the hip joint, leading to bone death and eventual collapse of the ball-shaped part of the hip joint.
The early symptoms of Legg-Calve-Perthes disease may include limping, stiffness in the hip or knee area, and mild pain in the groin or thigh region. These signs may worsen over time as more damage occurs within the affected area.
As Legg-Calve-Perthes progresses, it can lead to reduced mobility and muscle strength in one leg compared to the other. Children may experience difficulty with physical activities such as running or jumping due to limited range of motion caused by pain and stiffness.
There are a variety of treatment options available for Legg-Calve-Perthes Disease, depending on the severity and stage of the condition. The goal of treatment is to relieve pain, improve mobility and prevent deformity in the hip joint.
For more advanced cases, non-surgical interventions such as physical therapy or bracing may be recommended. Physical therapy helps strengthen muscles around the hip joint while bracing provides support to keep the femoral head in place during movement.
In severe cases where there is significant damage to the hip joint, surgery may be required. Surgical options include osteotomy (reshaping of bone), arthroscopy (minimally invasive surgery) and in extreme cases total hip replacement.
Legg-Calve-Perthes disease is a condition that affects the hip joint in children. The cause of the disease is not yet fully understood, but it's believed that factors such as genetics and blood flow to the hip may play a role.
The symptoms of Legg-Calve-Perthes disease can range from mild pain and stiffness to severe disability. Early diagnosis and treatment are crucial for preventing complications like arthritis.
Fortunately, there are several treatment options available for children with Legg-Calve-Perthes disease including non-surgical approaches like physical therapy, bracing and medication as well as surgery in some cases.
1.
The use of biomarkers in the treatment of breast lumps is at a crossroads.
2.
According to JAMA, 5 alpha-reductase inhibitors are not significantly linked to prostate cancer mortality.
3.
How Do Younger People Fare With Stool Tests for CRC Screening?
4.
Dual Targeted CAR-T Yields 99% Response Rate in Pediatric ALL
5.
Is It Really Cancer? More Concerns About Accelerated Approval; Metformin and Cancer
1.
How Parvovirus B19 Affects Pregnant Women and Their Unborn Babies
2.
Breaking Barriers: Innovative Approaches in Brain Tumor Treatment
3.
Introduction to Immune Thrombocytopenic Purpura
4.
Unveiling the Chadwick Sign: A Revolutionary New Tool for Detecting Early Signs of Cancer
5.
The Different Types of Cysts and Why They Occur: Insights from a Dermatologist
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Current Cancer Scenario in India- Importance of Genomic Testing & Advancement in Diagnosis and Treatment
2.
Preventing Blood Clots: The Importance of Venous Thromboembolism Management
3.
A Panel Discussion on Clinical Trial End Point for Tumor With PPS > 12 months
4.
Newer Immunotherapies for Myeloma- A Comprehensive Overview
5.
Navigating the Complexities of Ph Negative ALL - Part XII
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation